Login to Your Account



$1 Billion Deal With Novartis Opens Options For Morphosys

By Cormac Sheridan


Wednesday, December 5, 2007
During the first half of 2008, Morphosys AG plans to set out the shape of its future drug development strategy, following its mega-scale antibody discovery and development deal with Novartis AG, which the company estimates will deliver $1 billion in cash over the next 10 years. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription